Allergan

Madison, United States Founded: 1948 • Age: 78 yrs Acquired By Pharmaron
A portfolio of generic medicines is developed and manufactured.

About Allergan

Allergan is a Healthcare company based in Madison (United States) founded in 1948 by Gavin S Herbert, and was acquired by Pharmaron in March 2021. A portfolio of generic medicines is developed and manufactured. Allergan has completed 28 acquisitions, including Akarna Therapeutics, Anterios and AqueSys. Its focus areas include Diversified Pharmaceuticals and Drugs. Its competitors include Roivant Sciences, AbbVie and Gilead; 1 of its 3 listed competitors has raised funding.

Company details

Allergan was founded in 1948 in Madison, United States, as a pharmaceutical company. Generic medicines are developed and manufactured, with focus placed on therapeutic areas including dermatology, aesthetics, central nervous system disorders, eye care, womens health, urology, gastrointestinal and cystic fibrosis treatments, cardiovascular conditions, and infectious diseases. Operations are centered in the United States, supporting a range of medical needs through established production processes.

  • Headquarters Madison, United States
  • Founders Gavin S Herbert
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website allergan.com
  • Social LinkedIn
  • Acquired by Pharmaron (Mar 2021)
Key Metrics

Apps and channels of Allergan

Allergan publishes 1 mobile app with over 500K+ downloads.

Allē
Google Play Medical Everyone Free 500K+ downloads
Developer: AbbVie
View on Google Play

Funding Insights of Allergan

  • Total Rounds 8
  • First Round $226,281

    (Mar 2008)

  • Investors Count 4

All 8 funding rounds of Allergan with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2018Post-IPO––
Sep 2011$4MGrant––
Mar 2010$340,859Grant––
Sep 2009$2.76MGrant––
Sep 2009$1.7MGrant––
Aug 2008$312,655Grant––
Jul 2008$148,215Grant––
Mar 2008$226,281Grant––
Valuation history

8 investors in total: 7 institutional and 1 angel.

Investors in Allergan

Allergan has secured backing from 8 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include AbbVie, Pharmaron and Pfizer.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
sbir.nih.gov
Public health and human services are overseen by HHS.
1953hhs.gov
Administers health care and support for military personnel and operations.
health.milFalls Church, United States
Drug discovery and development services for small molecules are provided.
2003pharmaron.comBeijing, China
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012abbvie.comChicago, United States
Pharmaceutical products for treating multiple diseases are provided.
1849pfizer.comNew York, United States

Carl Icahn

unknown_deda00dd56164da19
Manufacturer of generic products
1956actavis.comParsippany Troy Hills, United States
Premium access

Investor details for Allergan

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Abbvie Healthcare India Private Limited (Allergan)

The board of Abbvie Healthcare India Private Limited currently have 3 directors; the longest-serving is Suresh Pattathil, appointed in 2022. 22 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Suresh Pattathil
DIN 02748206
Director25 Aug 20224 yrs 2 moAbbvie Healthcare India Private Limited
Vidhan Kedia
DIN 06718606
Director25 Jan 20233 yrs 9 moAbbvie Healthcare India Private Limited
Hong Liu Shi
DIN 10424175
Director11 Jan 20242 yrs 10 moAbbvie Healthcare India Private Limited

People of Allergan

1491 people are tracked at Allergan (744 in leadership, 12 in board & advisors, 735 in team).

NameRoleGroup
Gavin S Herbert
FounderLeadership
Dana Overbey
Global Sr Director Vendor Management Office And Technology Asset ManagementLeadership
Lauren Yarnell
Executive Assistant To The Svp, Abbvie & President, Specialty & U.s. Therapeutics OperationsLeadership
Martin Hayes
Chief Of Staff, Global Neuroscience & Ophthalmology ResearchLeadership
Brad Pignatello
Director Ii, Payer Strategy Eye Care - US Market AccessLeadership
Bruce Dannan
Director, Commercial Business TechnologyLeadership
Aimee Marx
Head Of Marketing US Patient ServicesLeadership
Bardia Akbari
Vice President - Development Operations OncologyLeadership
Sarah Cantor
Marketing Director - Access, Advocacy, And Non-retailLeadership
Nisha Patel Burns
Senior Vice President, AbbVie and President, Specialty and U.S. Therapeutics OperationsLeadership
Michael Schaffer
Director Ii, Neurology Franchise LeadLeadership
Mohamed Haytham
General Manager - North AfricaLeadership
Amanda Arlis
DirectorLeadership
Katie Stromsborg
Director Of Business Training And DevelopmentLeadership
Ana Alzugaray Beitia
CFO SpainLeadership
Alicia Subasinghe
Senior Director, Patient AdvocacyLeadership
April Hughes
Associate Marketing Director, ImmunologyLeadership
Paula Lima
Oncology Patient (consumer) Marketing Associate DirectorLeadership
Cormac Dalton
Vice President Sterile ManufacturingLeadership
Edgar Torres
Director, TransformationLeadership

1471 more people are available in the full profile.

Premium access

Complete people profiles for Allergan

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Allergan

Figures of Abbvie Healthcare India Private Limited, the primary company behind Allergan, for FY 2025. Revenue was ₹179 Cr (+7% year on year). Net loss was -₹1.11 Cr (-1% margin). EBITDA was ₹8.42 Cr (5% margin). Revenue has grown at a compounded annual rate of +15% over three years and +10% over five years.

  • ₹179 CrRevenue · FY 2025 · +7% YoY
  • -₹1.11 CrNet loss · -1% margin
  • ₹8.42 CrEBITDA · 5% margin
  • ₹2.15 CrPaid-up capital
  • 157Employees (provident fund records)
  • +15%Revenue CAGR, 3 years
  • +10%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Abbvie Healthcare India Private Limited are on its company page.

Premium access

Detailed financial statements for Allergan

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Allergan

Allergan has strategically engaged in corporate development activities, having acquired 28 companies. Notable acquisitions include Akarna Therapeutics, Anterios and AqueSys.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Brand of skin care products
envymedical.comLong Beach, United States1999Mar 2019β€’β€’β€’β€’
Botulinum neurotoxins are developed for musculoskeletal pain treatment.
bonti.comNewport Beach, United States2015Sep 2018$195M
Company offering solutions for cell growth and tissue repair through their Elastin technology
elastagen.comSydney, Australia2003Feb 2018$95M
Oral small molecule drugs are developed for reproductive health issues.
reprosrx.comThe Woodlands, United States1987Dec 2017β€’β€’β€’β€’
Anti-aging skin care products are developed using growth factor technology.
regenica.comSan Diego, United States2008Jul 2017β€’β€’β€’β€’
Silicone gel implant delivery devices are manufactured for surgical use.
kellerfunnel.comStuart, United States2009Jun 2017β€’β€’β€’β€’
Controlled cooling technology is developed for non-surgical fat reduction.
zeltiq.comPleasanton, United States2005Feb 2017$2.47B
Tissue repair products for regenerative medicine are developed and marketed.
lifecell.comUnited States1986Dec 2016$2.9B
Developer of drugs improve cognition and behavioral symptoms associated with Alzheimer’s disease
chasepharmaceuticals.comUnited States2007Nov 2016$125M
Therapeutics for medical treatments are developed by Tobira Therapeutics.
tobiratherpeutics.com2006Nov 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for Allergan

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Allergan

17 dated milestones of Allergan across 73 years, from founding to its latest funding, stage changes and deals.

  1. Founded Allergan is founded.
  2. Funding First funding round of $226K.
  3. Exit Acquired by Actavis.
  4. Exit Acquired by Pfizer.
  5. Acquisition Acquires Tobira Therpeutics.
  6. Acquisition Acquires Chase Pharmaceuticals.
  7. Acquisition Acquires LifeCell.
  8. Acquisition Acquires Zeltiq.
  9. Acquisition Acquires Keller Medical.
  10. Acquisition Acquires Regenica.
  11. Acquisition Acquires Repros Therapeutics.
  12. Acquisition Acquires Elastagen.
  13. Funding Latest funding round, Post-IPO,.
  14. Acquisition Acquires Bonti.
  15. Acquisition Acquires Envy Medical.
  16. Exit Acquired by AbbVie.
  17. Exit Acquired by Pharmaron.

Competitors of Allergan

Allergan has 3 listed competitors in our database, 1 of them funded. They include Roivant Sciences, AbbVie and Gilead.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
roivant.com2014New York, United States$1.3B662
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
abbvie.com2012Chicago, United States8,667
Biopharmaceutical research and drug development are conducted globally by AbbVie.
gilead.com1987Foster, United States4,267
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
Premium access

Detailed competitors of Allergan

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Allergan

The website of Allergan (allergan.com) receives about 7.2K visits a month.

  • Monthly visits
    7.2K

    ▲ 7.1% vs previous month

Similar websites

Websites whose visitors overlap most with Allergan. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
alcon.com
100%
171K#286,128View details
lilly.com
100%
4.9M#13,252View details
abbott.com
96%
917.2K#65,577View details
bms.com
86%
809.8K#67,210View details
baxter.com
85%
401.8K#127,908View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 18 similar websites and full traffic analytics for Allergan

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 18 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as Allergan (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 5.33 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Allergan

Premium access

Complete news archive for Allergan

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Allergan

Allergan was founded in 1948 and raised its 1st funding round 60 years after it was founded.

Allergan is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.

Allergan was founded in 1948 in Madison, United States, as a pharmaceutical company. Generic medicines are developed and manufactured, with focus placed on therapeutic areas including dermatology, aesthetics, central nervous system disorders, eye care, womens health, urology, gastrointestinal and cystic fibrosis treatments, cardiovascular conditions, and infectious diseases. Operations are centered in the United States, supporting a range of medical needs through established production processes.

Allergan's top competitors include Roivant Sciences, AbbVie and Gilead.

Allergan has made 28 acquisitions, including Akarna Therapeutics, Anterios, and AqueSys.

Allergan has 8 investors. Key investors include AbbVie, Pharmaron, Pfizer, HHS, and Actavis.

Allergan is associated with 2 legal entities: Abbvie Healthcare India Private Limited, Allergan India Private Limited.

Yes. Allergan was acquired by Pharmaron in March 2021.

The legal entities of Allergan currently have 3 directors, including Suresh Pattathil, Hong Liu Shi, Vidhan Kedia.

Yes. Allergan publishes AllΔ“, with over 500,000 downloads.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available